News

Washingron DC, USA.

The NovellusDx was attending the AACR annual meeting. Gabi Tarcic, PhD, our VP R&D was presenting a study recently conducted with Dr. Nir Peled from the Davidoff Cancer Center: Novel platform to profile variants of uncertain significant (VUS) with preliminary retrospective clinical validation in non-small cell lung cancer (NSCLC).